Medtech innovation is accelerating, creating new possibilities for how and where patients receive care. In this episode of PwC’s Next in Health, Glenn Hunzinger and Brent Hill are joined by Darshana Zaveri, co-founder and managing partner of Catalyst Health Ventures, and Geoff Pardo, general partner at Gilde Healthcare, for part one of a two-part conversation on the next wave of medtech innovation. From AI and connected care to less invasive technologies, robotics, and the shift beyond the hospital, the conversation explores the technologies and market trends reshaping medtech and where investors and innovators see the greatest opportunities ahead.

Discussion highlights:

• How medtech innovation is evolving toward less invasive, more scalable, and increasingly connected technologies
• AI’s growing role in devices, clinical decision-making, and connected care
• The shift from hospitals to ambulatory settings and the home and what it means for medtech companies
• Emerging opportunities across neuromodulation, robotics, biomaterials, drug-device combinations, and remote monitoring
• The balance between creating entirely new categories and building on established markets
• The growing importance of clinical evidence and data in driving adoption and improving patient care

Speakers:

Glenn Hunzinger, US Health Industries Leader, PwC
Darshana Zaveri, Co-founder and Managing Partner, Catalyst Health Ventures
Geoff Pardo, General Partner, Gilde Healthcare
Brent Hill, Managing Director, Medtech Strategy, PwC

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.